Children who are Palestinian refugees at school in Ein El Hilweh, Lebanon.

Source: Fouad Choufany / Education Cannot Wait

pandemic prevention, preparedness and response

We have all experienced living through a global pandemic. COVID-19 will not be the last pathogen with global pandemic potential. Since the start of the millennium, the world has already experienced several high-impact disease events including COVID-19, bird flu, Ebola and Zika virus. Despite the high likelihood of another pandemic, the world’s approach to pandemic prevention, preparedness and response (PPPR) is severely underfunded, unevenly supplied and inaccessible to many.

As well as causing direct health risks, pandemics can also disrupt health programmes such as routine immunisation, and stall progress made in the eradication of other diseases such as tuberculosis and polio.

how we take action

Coalition for Epidemic Preparedness Innovations (CEPI)

Results has argued for the funding of the Coalition for Epidemic Preparedness Innovations (CEPI). This is an international foundation which funds vaccine research and development for emerging infectious diseases with epidemic or pandemic potential.

100 Days Mission

The ‘100 Days Mission’ is a G7 initiative to reduce the timeline from a pandemic threat being identified to the creation of safe and effective diagnostics and treatments to just 100 days. We advocate for the UK to take a leading role in making the 100 Days Mission a funded reality.

health equity and PPPR

The COVID-19 pandemic demonstrated that global health responses are not always equitable. While many people in wealthy countries such as the UK received several doses of vaccines, many in low income countries have had none. We push for low-income countries to have greater access to medicines, diagnostics and vaccines during global health emergencies.

Results UK wins

Results’ advocacy has helped contribute to the UK playing an important role in global pandemic prevention, preparedness and response. For example, in 2020, the UK Government pledged up to £571 million to COVAX, a worldwide initiative aimed at equitable access to COVID-19 vaccines.

Results advocacy was critical to support the agreement to the 100 Days Mission by the G7 leaders in 2023. And at the UN High-Level Meetings on Universal Health Coverage, TB and PPR in New York, the UK announced an almost £500 million global health package to boost health security, improve health and wellbeing around the world, and help achieve the Sustainable Development Goals.